Anum Saeed

Has grant

Assistant Professor

University of Pittsburgh School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anum Saeed is an Assistant Professor at the University of Pittsburgh School of Medicine, United States. Her research focuses on cardiovascular health, specifically sex differences in statin utilization, coronary artery disease care gaps, and the impact of anti-inflammatory metabolites on cardiovascular disease outcomes. She has contributed significantly to the understanding of cardiovascular risk factors associated with Alzheimer's disease and has published extensively on various treatment outcomes for patients with type 2 diabetes.

Recent Grants

Grant: Close

Association of Mid-life Cardiovascular Disease and Late-life Biomarkers of Alzheimer's Disease

Open Date: 2023-04-01

Close Date: 2026-03-31

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Steven Reis

University of Pittsburgh

UNITED STATES

View details

Elizabeth Dineen

Assistant Professor

University of California, Irvine

UNITED STATES

View details

Marnie Bertolet

University of Pittsburgh

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anum Saeed

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (17)

Sex differences in guideline-based statin utilization and recurrent events in patients with known coronary artery disease

Population-Level Gaps in Coronary Artery Disease Care: A Focused Review

Annals On Call - Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes

Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes

Treatment of severe hyperlipidemia and associated cardiovascular outcomes: Data from a large healthcare system

Mid-life anti-inflammatory metabolites are inversely associated with long-term cardiovascular disease events

Association of mid-life cardiovascular risk with biomarkers of Alzheimer's disease, neurodegeneration, and white matter hyperintensities: Heart SCORE brain study

Long term association of low-density lipoprotein subtypes with coronary artery calcium score and atherosclerotic cardiovascular disease events: Insights from HeartSCORE study

Apolipoprotein E and Alzheimer's disease pathology in African American older adults

Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adults.

Racial/Ethnic Disparities and Determinants of Sufficient Physical Activity Levels.

PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance.

Lipoprotein(a) and ethnicities.

Reinforcing Cardiology Training During a Pandemic: An Open Letter to Our Leaders

Reinforcing Cardiology Training During a Pandemic

Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study.

Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.

Collaborators (3)

Steven Reis

Elizabeth Dineen

Marnie Bertolet

Make your next move.